• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cellectis S.A. - American Depositary Shares (NQ:CLLS)

4.540 -0.260 (-5.42%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 58,341
Open 4.740
Bid (Size) 4.440 (500)
Ask (Size) 5.200 (7,000)
Prev. Close 4.800
Today's Range 4.490 - 4.864
52wk Range 1.100 - 5.480
Shares Outstanding 45,484,310
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Traders are paying attention to the gapping stocks in Monday's session. ↗
December 29, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday. 
Via Chartmill
News headline image
Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis
December 15, 2025
From Allogene Therapeutics, Inc.
Via GlobeNewswire

Performance

YTD
-5.4%
-5.4%
1 Month
-1.7%
-1.7%
3 Month
+28.6%
+28.6%
6 Month
+183.8%
+183.8%
1 Year
+113.1%
+113.1%

More News

Read More
News headline image
Cellectis Announces Arbitral Decision in Dispute with Servier
December 15, 2025
From Cellectis Inc.
Via GlobeNewswire
News headline image
Cellectis Earnings Preview ↗
November 06, 2025
Via Benzinga
News headline image
ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL
December 08, 2025
From Cellectis Inc.
Via GlobeNewswire
News headline image
Why Cellectis Stock Is Trading Higher Today ↗
November 19, 2025
Via Benzinga
News headline image
European ADRs Navigate Choppy Waters: Pharma Sector Shows Resilience Amidst Broader Market Volatility
November 19, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
News headline image
Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells
November 19, 2025
From Cellectis Inc.
Via GlobeNewswire
News headline image
Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update
November 07, 2025
From Cellectis Inc.
Via GlobeNewswire
News headline image
Cellectis to Present a Development Update for eti-cel at ASH 2025
November 03, 2025
From Cellectis Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 7, 2025 ↗
November 07, 2025
Via Benzinga
News headline image
Cellectis to Report Third Quarter Financial Results on November 7, 2025
October 31, 2025
From Cellectis Inc.
Via GlobeNewswire
News headline image
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
October 20, 2025
Via Benzinga
News headline image
Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL
October 16, 2025
From Cellectis Inc.
Via GlobeNewswire
News headline image
Thursday's session: gap up and gap down stocks ↗
October 16, 2025
Via Chartmill
News headline image
Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursday ↗
October 16, 2025
Via Benzinga
News headline image
Top 2 Health Care Stocks That May Keep You Up At Night This Month ↗
October 16, 2025
Via Benzinga
News headline image
Stay updated with the stocks that are on the move in today's pre-market session. ↗
October 16, 2025
Via Chartmill
News headline image
Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers
October 16, 2025
From Cellectis Inc.
Via GlobeNewswire
News headline image
Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress
October 07, 2025
From Cellectis Inc.
Via GlobeNewswire
News headline image
Wondering what's happening in today's pre-market session? ↗
September 29, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
September 29, 2025
Via Benzinga
News headline image
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
September 29, 2025
Via Benzinga
Topics Stocks
News headline image
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket ↗
September 29, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
September 19, 2025
Via Benzinga

Frequently Asked Questions

Is Cellectis S.A. - American Depositary Shares publicly traded?
Yes, Cellectis S.A. - American Depositary Shares is publicly traded.
What exchange does Cellectis S.A. - American Depositary Shares trade on?
Cellectis S.A. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Cellectis S.A. - American Depositary Shares?
The ticker symbol for Cellectis S.A. - American Depositary Shares is CLLS on the Nasdaq Stock Market
What is the current price of Cellectis S.A. - American Depositary Shares?
The current price of Cellectis S.A. - American Depositary Shares is 4.540
When was Cellectis S.A. - American Depositary Shares last traded?
The last trade of Cellectis S.A. - American Depositary Shares was at 01/05/26 04:00 PM ET
What is the market capitalization of Cellectis S.A. - American Depositary Shares?
The market capitalization of Cellectis S.A. - American Depositary Shares is 206.50M
How many shares of Cellectis S.A. - American Depositary Shares are outstanding?
Cellectis S.A. - American Depositary Shares has 206M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap